Solarea Bio News and Activities

View the org chart displaying its 4 main executives

Most searched biographies at Solarea Bio

• Catherine Balsam-Schwaber, Chief Executive Officer
• David Easson, Chief Manufacturing Officer
• Eric Schott, Co-Founder and Chief Operating Officer

Popular executive movements at Solarea Bio

• Gerardo Toledo, Co-Founder, Chief Executive Officer and Director, has left the company  (posted on October 6 2025).
• Juliana Soto, Translational Bioinformatics Lead, has left the company  (posted on October 6 2025).
• Ilissa Larimore, Chief Commercial Officer, has left the company  (posted on October 6 2025).

Click here to view some more movements at Solarea Bio

Create your alert
to follow the executive moves at Solarea Bio.

Solarea Bio has 2,417 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Zymeworks has announced the acquisition of Theravance Biopharma  (posted on June 29 2026).
• Tissium has just announced a $68 Million fundraising (posted on June 29 2026).
• Oblenio Bio has just announced a $62 Million fundraising (posted on June 26 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Solarea Bio

• NIH/National Institute on Aging’s $3 million R01 Grant supports study evaluating probiotic/prebiotic combination’s impact on maintaining bone health of older women

Social media about Solarea Bio

• Solarea Bio on Wikipedia, Google News & Yahoo Finance
• Solarea Bio on LinkedIn, X (Twitter) & YouTube